State Street’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
VCM
SWM
State Street's SMTI Position: Q1 2026 in Review
State Street increased its Sanara MedTech (SMTI) stake by 0.64% in Q1 2026, buying an estimated $8.23K and bringing the position to 62,689 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3472.
State Street first reported a position in SMTI in Q2 2021 and has held it in 19 quarters since. The position peaked at $2.19M in Q4 2023. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.
- State Street held 62,689 shares of Sanara MedTech worth $1.08M as of Q1 2026.
- State Street bought 400 Sanara MedTech shares in Q1 2026, an estimated $8.23K.
- Sanara MedTech made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3472 holding.
- State Street first reported a position in Sanara MedTech in Q2 2021 and has held it in 19 quarters since.
- State Street's Sanara MedTech position peaked at $2.19M in Q4 2023.
- 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.